Cargando…

Effects of dexmedetomidine on the expression of inflammatory factors in children with congenital heart disease undergoing intraoperative cardiopulmonary bypass: a randomized controlled trial

IMPORTANCE: Dexmedetomidine inhibits the inflammatory response associated with cardiopulmonary bypass (CPB) and protects neural function. However, the mechanism of dexmedetomidine’s anti‐inflammatory pathway is unclear. OBJECTIVE: To investigate the effect of dexmedetomidine on the cognitive level a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Yongsheng, Li, Chan, Li, Xiaoqin, Jia, Yingping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331422/ https://www.ncbi.nlm.nih.gov/pubmed/32851338 http://dx.doi.org/10.1002/ped4.12176

Ejemplares similares

Application of Dexmedetomidine in Cardiopulmonary Bypass Prefilling
por: Wang, Li, et al.
Publicado: (2020)

Post-Bypass Dexmedetomidine Use and Postoperative Acute Kidney Injury in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass
por: Ji, Fuhai, et al.
Publicado: (2013)

Response to Letter: Application of Dexmedetomidine in Cardiopulmonary Bypass Prefilling
por: Wang, Li
Publicado: (2020)

Dexmedetomidine decreases the inflammatory response to myocardial surgery under mini-cardiopulmonary bypass
por: Bulow, N.M.H., et al.
Publicado: (2016)

Normoxic and Hyperoxic Cardiopulmonary Bypass in Congenital Heart Disease
por: Mokhtari, Amir, et al.
Publicado: (2014)

Comparison of Early Outcomes for Normothermic and Hypothermic Cardiopulmonary Bypass in Children Undergoing Congenital Heart Surgery
por: Corno, Antonio F., et al.
Publicado: (2018)

Cardiopulmonary Bypass Down-Regulates NOD Signaling and Inflammatory Response in Children with Congenital Heart Disease
por: Yang, Qinghua, et al.
Publicado: (2016)

Effects of cardiopulmonary bypass with low-priming volume on clinical outcomes in children undergoing congenital heart disease surgery
por: Wang, Lei, et al.
Publicado: (2020)

Myocardial protective and anti-inflammatory effects of dexmedetomidine in patients undergoing cardiovascular surgery with cardiopulmonary bypass: a systematic review and meta-analysis
por: Chen, Milian, et al.
Publicado: (2021)

Derangement of Arginine and Related Amino Acids in Children Undergoing Surgery for Congenital Heart Disease With Cardiopulmonary Bypass
por: Navaei, Amir H., et al.
Publicado: (2020)

Popular Hybrid Congenital Heart Procedures without Cardiopulmonary Bypass
por: Gupta, Aamisha, et al.
Publicado: (2017)

Application of Dexmedetomidine in Cardiopulmonary Bypass Prefilling and Several Confounding Factors
por: Bae, Sung, et al.
Publicado: (2020)

The JAK2/STAT3 pathway is involved in dexmedetomidine-induced myocardial protection in rats undergoing cardiopulmonary bypass
por: Pan, Sining, et al.
Publicado: (2020)

Dexmedetomidine as a myocardial protector in pediatric heart surgery using cardiopulmonary bypass: a systematic review
por: Kesumarini, Dian, et al.
Publicado: (2023)

Post-cardiopulmonary bypass hypoxaemia in paediatric patients undergoing congenital heart disease surgery: risk factors, features, and postoperative pulmonary complications
por: Sun, Yuan, et al.
Publicado: (2022)

Non-thyroidal illness syndrome and cardiopulmonary bypass in children with congenital heart disease
por: Babazadeh, Kazem, et al.
Publicado: (2014)

The outcome of pediatric patients undergoing congenital cardiac surgery under pulsatile cardiopulmonary bypass in different frequencies
por: Li, Guanhua, et al.
Publicado: (2018)

Strategies to prevent intraoperative lung injury during cardiopulmonary bypass
por: Apostolakis, Efstratios E, et al.
Publicado: (2010)

Effect of high-dose ulinastatin on the cardiopulmonary bypass-induced inflammatory response in patients undergoing open-heart surgery
por: Liu, Yu, et al.
Publicado: (2020)

Protective continuous ventilation strategy during cardiopulmonary bypass in children undergoing surgery for congenital heart disease: a prospective study
por: Padalino, Massimo A, et al.
Publicado: (2022)

The effect of intraoperative dexmedetomidine on acute kidney injury after pediatric congenital heart surgery: A prospective randomized trial
por: Jo, Youn Yi, et al.
Publicado: (2017)

Efficacy and Safety of Dexmedetomidine for Postoperative Delirium in Adult Cardiac Surgery on Cardiopulmonary Bypass
por: Park, Jae Bum, et al.
Publicado: (2014)

Efficacy of dexmedetomidine on myocardial ischemia/reperfusion injury in patients undergoing cardiac surgery with cardiopulmonary bypass: A protocol for systematic review and meta-analysis
por: Liang, Gencheng, et al.
Publicado: (2023)

Differential expression of microRNAs following cardiopulmonary bypass in children with congenital heart diseases
por: Abu-Halima, Masood, et al.
Publicado: (2017)

Simultaneous repair of pectus excavatum and congenital heart disease without cardiopulmonary bypass or sternal osteotomy
por: Sun, Yong, et al.
Publicado: (2014)

The Microbiome is a Welcome Addition to the Growing “Omes” of Cardiopulmonary Bypass in Congenital Heart Disease Surgery
por: Watson, John D., et al.
Publicado: (2021)

Dysbiosis and Intestinal Barrier Dysfunction in Pediatric Congenital Heart Disease Is Exacerbated Following Cardiopulmonary Bypass
por: Salomon, Jeffrey, et al.
Publicado: (2021)

Effect of preoperative pulmonary hemodynamic and cardiopulmonary bypass on lung function in children with congenital heart disease
por: Simonato, Manuela, et al.
Publicado: (2023)

Validation of Open-Heart Intraoperative Risk score to predict a prolonged intensive care unit stay for adult patients undergoing cardiac surgery with cardiopulmonary bypass
por: Tribuddharat, Sirirat, et al.
Publicado: (2018)

Dexmedetomidine dosage in critically ill patients undergoing intraoperative wake-up test: A randomized controlled trial
por: Yang, Ting, et al.
Publicado: (2022)

Does transfusion of residual cardiopulmonary bypass circuit blood increase postoperative bleeding? A prospective randomized study in patients undergoing on pump cardiopulmonary bypass
por: Duara, Rajnish, et al.
Publicado: (2008)

Effect of dexmedetomidine on hemodynamic changes and inflammatory responses in patients undergoing off-pump coronary-artery bypass grafting
por: Zhai, Wenqian, et al.
Publicado: (2020)

Oral Dexmedetomidine Versus Midazolam as Anesthetic Premedication in Children Undergoing Congenital Heart Surgery
por: Faritus, Seyedeh Zahra, et al.
Publicado: (2015)

Comparison of intraoperative tranexamic acid and epsilon-aminocaproic acid in cardiopulmonary bypass patients
por: Broadwin, Mark, et al.
Publicado: (2020)

Is the Cardiopulmonary Bypass Systemic Inflammatory Response Overestimated?
por: Evora, Paulo Roberto B., et al.
Publicado: (2018)

Role of dexmedetomidine and sevoflurane in the intraoperative management of patient undergoing resection of phaeochromocytoma
por: Khetarpal, Monica, et al.
Publicado: (2014)

Association of intraoperative hyperglycemia with postoperative composite infection after cardiac surgery with cardiopulmonary bypass: A retrospective cohort study
por: Xiong, Xinglong, et al.
Publicado: (2023)

Efficacy of inhaled iloprost in the management of pulmonary hypertension after cardiopulmonary bypass in infants undergoing congenital heart surgery. A case series of 31 patients
por: Müller, M, et al.
Publicado: (2011)

Protocol for a prospective cohort study exploring the gut microbiota of infants with congenital heart disease undergoing cardiopulmonary bypass (the GuMiBear study)
por: Magner, Claire, et al.
Publicado: (2023)

Oral neutrophil quantitation in patients undergoing elective cardiopulmonary bypass
por: Wilcox, ME, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_a0orhf6r3ajivc59ca7g30ccla